Evidence for positive selection on Mycobacterium tuberculosis within patients

被引:8
|
作者
Tanaka, MM [1 ]
机构
[1] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia
关键词
D O I
10.1186/1471-2148-4-31
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: While the pathogenesis and epidemiology of tuberculosis are well studied, relatively little is known about the evolution of the infectious agent Mycobacterium tuberculosis, especially at the within-host level. The insertion sequence IS6110 is a genetic marker that is widely used to track the transmission of tuberculosis between individuals. This and other markers may also facilitate our understanding of the disease within patients. Results: This article presents three lines of evidence supporting the action of positive selection on M. tuberculosis within patients. The arguments are based on a comparison between empirical findings from molecular epidemiology, and population genetic models of evolution. Under the hypothesis of neutrality of genotypes, 1) the mutation rate of the marker IS6110 is unusually high, 2) the time it takes for substitutions to occur within patients is too short, and 3) the amount of polymorphism within patients is too low. Conclusions: Empirical observations are explained by the action of positive selection during infection, or alternatively by very low effective population sizes. I discuss the possible roles of antibiotic treatment, the host immune system and extrapulmonary dissemination in creating opportunities for positive selection.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Evidence for positive selection on Mycobacterium tuberculosis within patients
    Mark M Tanaka
    BMC Evolutionary Biology, 4
  • [2] Genes under positive selection in Mycobacterium tuberculosis
    Zhang, Yuan
    Zhang, Hong
    Zhou, Tianyin
    Zhong, Yang
    Jin, Qi
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2011, 35 (05) : 319 - 322
  • [3] Mycobacterium tuberculosis sensitivity to antituberculous drugs in HIV - Positive patients
    Mugabo, P
    Mohutsioa, P
    Ward, KL
    Pomario, B
    Hassan, S
    XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE, 2002, : 209 - 212
  • [4] Evidence for recombination in Mycobacterium tuberculosis
    Liu, Xiaoming
    Gutacker, Michaela M.
    Musser, James M.
    Fu, Yun-Xin
    JOURNAL OF BACTERIOLOGY, 2006, 188 (23) : 8169 - 8177
  • [5] Inhibiting Mycobacterium tuberculosis within and without
    Cole, Stewart T.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2016, 371 (1707)
  • [6] Mycobacterium tuberculosis and the environment within the phagosome
    Rohde, Kyle
    Yates, Robin M.
    Purdy, Georgiana E.
    Russell, David G.
    IMMUNOLOGICAL REVIEWS, 2007, 219 : 37 - 54
  • [7] The relative frequency of Mycobacterium tuberculosis and Mycobacterium avium infections in HIV positive patients,Ahvaz,Iran
    Khosravi AD
    Seyed Mohammad Alavi
    Hashemzade M
    Abasi E
    Seghatoleslami S
    Asian Pacific Journal of Tropical Medicine, 2012, (01) : 71 - 74
  • [8] Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients
    Bondarenko, Vasily
    Buynevich, Irina
    Holyavkin, Andrey
    Goponyako, Svetlana
    Burinsky, Nkolaj
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [9] The relative frequency of Mycobacterium tuberculosis and Mycobacterium avium infections in HIV positive patients, Ahvaz, Iran
    Khosravi, A. D.
    Alavi, S. M.
    Hashemzade, M.
    Abasi, E.
    Seghatoleslami, S.
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2012, 5 (01) : 71 - 74
  • [10] MYCOBACTERIUM-TUBERCULOSIS PNEUMONIA IN 2 HIV ANTIBODY POSITIVE PATIENTS
    HARRIS, PE
    MORRISON, SM
    SADANA, A
    PEARSON, R
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1989, 43 (11): : 414 - 416